Medicare Drug Pricing In Court: Judge Praises ‘Zealous Advocacy’ Of Attorneys In First Hearing On IRA

DOJ and Chamber of Commerce attorneys argue over whether Chamber has standing to sue and whether AbbVie has suffered harm meriting a preliminary injunction to halt the program. With Medicare’s Oct. 2 deadline looming, Judge Newman said he would issue a decision ‘as quickly as we can.’

Chamber of Commerce hearing on IRA 09 15 2023
DOJ brought two attorneys to the Zoom fight. • Source: Screenshot

Judge Michael Newman asked no questions during the first court hearing on the Inflation Reduction Act’s Medicare price negotiation program but expressed appreciation for the arguments of the attorneys representing the US Chamber of Commerce and the US government, which included discussion of what the CEO of Novo Nordisk A/S meant in comments about the program’s impact on his company’s drugs.

More from Legal & IP

More from Pink Sheet

EU Explores Boosting Nanomedicine Innovation

 
• By 

A new EU horizon scanning report recommends changes to help regulators provide targeted support for developers of nanomedicines.

Advanced Therapies For Common Conditions In England Won’t Get Extra Funding, Says Ex-NICE Official

 

Health technology assessment agencies are willing to pay more than usual for advanced therapies that treat rare or severe diseases, but an advanced therapy for a common condition would not qualify for such a modifier, a former senior figure at England’s NICE says.

Opposition Tempers Cuts To Japan’s High-Cost Healthcare Benefits

 
• By 

Japan's MHLW has decided to tone down planned policy revisions that would have cut benefits under a patient support scheme for high-priced drugs, after resistance from patient groups.